Resource Center

Fresenius Kabi USA provides product availability information to assist healthcare professionals learn more about how Fresenius Kabi products may help their drug shortage needs.

You can reach a Customer Service Representative at (888) 386-1300, option 2. Customer Service is available Monday through Friday, between the hours of 7:00am - 6:00pm CST.

Customer Service can provide information regarding the availability of specific Fresenius Kabi products, as well as assist with ordering and tracking.

• Pharmaceutical Medical Information Request Form
• Infusion Delivery Medical Information Request
• Nutrition Medical Information Request Form
• Biosimilars Medical Information Request Form

American Society of Health-System Pharmacists: 
http://www.ashp.org/shortages

U.S. Food & Drug Administration:

https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages

Current Product Availability Report

Information contained on this page may not be up to date and is subject to change at any time without notice.

Product Availability Report Viewer

The Fresenius Kabi Medical Device Symbol Glossary includes symbols and definitions commonly used on Fresenius Kabi MedTech products.

Symbol Glossary Viewer

A new leukoreduction filter will be incorporated into the Alyx X4R5720 kit. Visual indicators (BI or SE) will be added to the Master Carton box and to the Red Cell Storage Container label to identify the kits produced with Bioflex RC XL (BI) filters versus Sepacell (SE) filters. Please reference the document below for finished good lots produced with Bioflex (BI) or Sepacell (SE) filters.

Alyx X4R5720 Filter Transition Viewer

To request a Going Home Guide, please fill out the form below. Once the information is completed, please send the form to fkgoinghomeguide@fresenius-kabi.com

MyFreseniusKabi.com Product Ordering

Your easy and convenient resource for information on the critical products you use every day from Fresenius Kabi.

Get real-time access to product information and customer support

• Browse the complete Fresenius Kabi product portfolio
• Access to product reference materials such as:
  •     Package Inserts
  •     Safety Data Sheets (SDS)
  •     Additional Product Information
  •     Wholesaler Item Numbers

Gain greater control over your complete Fresenius Kabi product inventory

• Check for product availability
• Place and track orders online
• View individual pricing detail
• Check shipping status
• Review account history
• Reference and print invoices

Register today to get started.

Our perspective and the steps we’ve taken

Fresenius Kabi opposes the use of our products in lethal injection, and along with other major drug manufacturers, we have established an Authorized Distribution program for certain restricted products.  This program is designed to assure the availability of key medications for patients.  Our medicines play a vital role in patient care. In keeping with our mission in healthcare Fresenius Kabi is committed to distribution controls that help assure restricted products are used for proper medical purposes.

While Fresenius Kabi takes no position on capital punishment, the use of our products for lethal injection is contrary both to our mission and to the FDA-approved indications for, and labelling of, our products.  Fresenius Kabi therefore does not sell, or allow the sale of, certain drugs to prisons or correctional facilities.

The majority of the company’s injectable medicines are manufactured in the United States, however for those made in Europe, the unauthorized use of our medications for lethal injection could also lead to sanctions by the European Union (EU).  This in turn could threaten the U.S. supply of important drugs, potentially putting patients at risk.

Please see our list of authorized distributors for restricted products.  It is updated periodically.  If you have questions, please feel free to contact your distributor, or Fresenius Kabi customer service at 888-386-1300.

Fresenius Kabi is committed to patient safety and responsible opioid use

Fresenius Kabi manufactures injectable opioids exclusively for controlled hospital and surgical settings under strict FDA and DEA regulations. To help prevent misuse and diversion, our products feature advanced safeguards such as secure packaging systems that aid in diversion deterrence, and ready-to-administer, low-dose formats. We also support opioid stewardship through education, compliance programs, and by offering non-opioid alternatives for pain management.

Controlled Hospital Use Only

Fresenius Kabi manufactures sterile injectable opioids (such as fentanyl) that are formulated and packaged for use exclusively in hospital and surgical settings. These medicines are administered by healthcare professionals (doctors and nurses), which minimizes the risk of misuse or diversion. Importantly, Fresenius Kabi does not produce oral solid opioids. 

Specialized Packaging and Ready-to-Administer Innovations 

To further enhance safety and prevent diversion, many of our opioid products are packaged in our proprietary MicroVault® and Simplist® prefilled syringe packaging systems, which are also optimized for locked medication dispensing cabinets in hospitals.

Strict Distribution Controls

Fresenius Kabi maintains controlled distribution agreements with licensed wholesalers. Products are sold only to authorized professionals, and internal monitoring systems flag suspicious orders. 

Compliance and Regulatory Oversight

All opioid products are manufactured and stored in facilities regulated by FDA and DEA, ensuring compliance with stringent safety standards. 

Non-Opioid Alternatives

To support safe pain management, Fresenius Kabi offers healthcare professionals a range of non-opioid medicines for pain therapy, allowing reduced reliance on opioids where possible.

Education and Partnerships

Fresenius Kabi collaborates with organizations like the American Society of Anesthesiologists and the Anesthesia Patient Safety Foundation to promote opioid stewardship and medication safety through educational programs and best practices for hospitals. 

In Summary

These combined measures—hospital-only use, strict distribution, compliance, education, innovative packaging and low-dose formats—are designed to maximize patient safety and minimize the risk of opioid misuse or diversion.